{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:37:04Z","timestamp":1791286624615,"version":"4.1.0"},"reference-count":149,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"abstract":"<jats:p>The mechanisms regulating cortisol production when ACTH of pituitary origin is suppressed in primary adrenal causes of Cushing's syndrome (CS) include diverse genetic and molecular mechanisms. These can lead either to constitutive activation of the cAMP system and steroidogenesis or to its regulation exerted by the aberrant adrenal expression of several hormone receptors, particularly G-protein coupled hormone receptors (GPCR) and their ligands. Screening for aberrant expression of GPCR in bilateral macronodular adrenal hyperplasia (BMAH) and unilateral adrenal tumors of patients with overt or subclinical CS demonstrates the frequent co-expression of several receptors. Aberrant hormone receptors can also exert their activity by regulating the paracrine secretion of ACTH or other ligands for those receptors in BMAH or unilateral tumors. The aberrant expression of hormone receptors is not limited to adrenal CS but can be implicated in other endocrine tumors including primary aldosteronism and Cushing's disease. Targeted therapies to block the aberrant receptors or their ligands could become useful in the future.<\/jats:p>","DOI":"10.1530\/eje-15-0200","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T01:52:17Z","timestamp":1431568337000},"page":"M45-M60","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":84,"title":["Multiple aberrant hormone receptors in Cushing's syndrome"],"prefix":"10.1093","volume":"173","author":[{"given":"Nada El","family":"Ghorayeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bourdeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2015082718040528000_173.4.M45.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68699-6"},{"key":"2015082718040528000_173.4.M45.2","doi-asserted-by":"crossref","unstructured":"Lacroix A, Feelders RA, Stratakis CE & Niemann LK. Cushing's syndrome. Lancet. 2015 In press. (doi:10.1016\/S0140-6736(14)61375-1).","DOI":"10.1016\/S0140-6736(14)61375-1"},{"key":"2015082718040528000_173.4.M45.3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-2722"},{"key":"2015082718040528000_173.4.M45.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2010.11.041"},{"key":"2015082718040528000_173.4.M45.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2011.10.006"},{"key":"2015082718040528000_173.4.M45.6","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2822"},{"key":"2015082718040528000_173.4.M45.7","doi-asserted-by":"publisher","DOI":"10.1210\/er.22.1.75"},{"key":"2015082718040528000_173.4.M45.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310359"},{"key":"2015082718040528000_173.4.M45.9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2152"},{"key":"2015082718040528000_173.4.M45.10","doi-asserted-by":"publisher","DOI":"10.1126\/science.1249480"},{"key":"2015082718040528000_173.4.M45.11","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2956"},{"key":"2015082718040528000_173.4.M45.12","doi-asserted-by":"publisher","DOI":"10.1126\/science.1252328"},{"key":"2015082718040528000_173.4.M45.13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020592"},{"key":"2015082718040528000_173.4.M45.14","doi-asserted-by":"publisher","DOI":"10.1086\/344579"},{"key":"2015082718040528000_173.4.M45.15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2708"},{"key":"2015082718040528000_173.4.M45.16","doi-asserted-by":"publisher","DOI":"10.1038\/79238"},{"key":"2015082718040528000_173.4.M45.17","doi-asserted-by":"publisher","DOI":"10.1038\/ng1809"},{"key":"2015082718040528000_173.4.M45.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2012.04366.x"},{"key":"2015082718040528000_173.4.M45.19","doi-asserted-by":"crossref","unstructured":"Mauras N Blizzard RM . The McCune-Albright syndrome. Acta Endocrinologica. Supplementum 1986 279 207\u2013217.","DOI":"10.1530\/acta.0.112S207"},{"key":"2015082718040528000_173.4.M45.20","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.55.091902.103843"},{"key":"2015082718040528000_173.4.M45.21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021362"},{"key":"2015082718040528000_173.4.M45.22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2321"},{"key":"2015082718040528000_173.4.M45.23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.3.875"},{"key":"2015082718040528000_173.4.M45.24","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(95)00114-L"},{"key":"2015082718040528000_173.4.M45.25","doi-asserted-by":"publisher","DOI":"10.1210\/me.2002-0099"},{"key":"2015082718040528000_173.4.M45.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2003.10.052"},{"key":"2015082718040528000_173.4.M45.27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4237"},{"key":"2015082718040528000_173.4.M45.28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4280"},{"key":"2015082718040528000_173.4.M45.29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1265"},{"key":"2015082718040528000_173.4.M45.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304603"},{"key":"2015082718040528000_173.4.M45.31","doi-asserted-by":"crossref","unstructured":"Espiard S Drougat L Libe R Assie G Perlemoine K Guignat L Barrande G Brucker-Davis F Doullay F Lopez S . ARMC5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences. Journal of Clinical Endocrinology and Metabolism 2015 100 E926\u2013E930. (doi:10.1210\/jc.2014-4204).","DOI":"10.1210\/jc.2014-4204"},{"key":"2015082718040528000_173.4.M45.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02387.x"},{"key":"2015082718040528000_173.4.M45.33","doi-asserted-by":"crossref","unstructured":"Elbelt U Trovato A Kloth M Gentz E Finke R Spranger J Galas D Weber S Wolf C Konig K . Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma. Journal of Clinical Endocrinology and Metabolism 2015 100 E119\u2013E128. (doi:10.1210\/jc.2014-2648).","DOI":"10.1210\/jc.2014-2648"},{"key":"2015082718040528000_173.4.M45.34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215245"},{"key":"2015082718040528000_173.4.M45.35","doi-asserted-by":"crossref","unstructured":"Lefebvre H Duparc C Prevost G Zennaro MC Bertherat J Louiset E . Paracrine control of steroidogenesis by serotonin in adrenocortical neoplasms. Molecular and Cellular Endocrinology 2015 408 198\u2013204. (doi:10.1016\/j.mce.2014.11.013).","DOI":"10.1016\/j.mce.2014.11.013"},{"key":"2015082718040528000_173.4.M45.36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106608"},{"key":"2015082718040528000_173.4.M45.37","unstructured":"Hamet P Larochelle P Franks DJ Cartier P Bolte E . Cushing syndrome with food-dependent periodic hormonogenesis. Clinical and Investigative Medicine 1987 10 530\u2013533."},{"key":"2015082718040528000_173.4.M45.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199210013271402"},{"key":"2015082718040528000_173.4.M45.39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199210013271403"},{"key":"2015082718040528000_173.4.M45.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2004.08.007"},{"key":"2015082718040528000_173.4.M45.41","doi-asserted-by":"crossref","unstructured":"Lacroix A Bourdeau I Lampron A Mazzuco TL Tremblay J Hamet P . Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction. Clinical Endocrinology 2010 73 1\u201315. (doi:10.1111\/j.1365-2265.2009.03689.x).","DOI":"10.1111\/j.1365-2265.2009.03689.x"},{"key":"2015082718040528000_173.4.M45.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2005.01.004"},{"key":"2015082718040528000_173.4.M45.43","doi-asserted-by":"crossref","unstructured":"Mermejo LM Mazzuco TL Grunenwald S Fragoso MC Bourdeau I Lacroix A . ACTH-independent macronodular adrenal hyperplasia. Endocrinology and Metabolism 2011 26 1. (doi:10.3803\/EnM.2011.26.1.1).","DOI":"10.3803\/EnM.2011.26.1.1"},{"key":"2015082718040528000_173.4.M45.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2008.10.011"},{"key":"2015082718040528000_173.4.M45.45","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.10.3531"},{"key":"2015082718040528000_173.4.M45.46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02048.x"},{"key":"2015082718040528000_173.4.M45.47","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0195"},{"key":"2015082718040528000_173.4.M45.48","doi-asserted-by":"crossref","unstructured":"Hofland J Hofland LJ van Koetsveld PM Steenbergen J de Herder WW van Eijck CH de Krijger RR van Nederveen FH van Aken MO de Groot JW . ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11\u03b2-hydroxylase. Orphanet Journal of Rare Diseases 2013 8 142. (doi:10.1186\/1750-1172-8-142).","DOI":"10.1186\/1750-1172-8-142"},{"key":"2015082718040528000_173.4.M45.49","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0516"},{"key":"2015082718040528000_173.4.M45.50","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.11.5534"},{"key":"2015082718040528000_173.4.M45.51","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2003.01963.x"},{"key":"2015082718040528000_173.4.M45.52","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-825797"},{"key":"2015082718040528000_173.4.M45.53","doi-asserted-by":"crossref","unstructured":"Joubert M Louiset E Rego JL Contesse V Kong LC Benhaim A Mittre H Lefebvre H Reznik Y Group RS . Aberrant adrenal sensitivity to vasopressin in adrenal tumours associated with subclinical or overt autonomous hypercortisolism: is this explained by an overexpression of vasopressin receptors? Clinical Endocrinology 2008 68 692\u2013699. (doi:10.1111\/j.1365-2265.2007.03106.x).","DOI":"10.1111\/j.1365-2265.2007.03106.x"},{"key":"2015082718040528000_173.4.M45.54","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0253"},{"key":"2015082718040528000_173.4.M45.55","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1256"},{"key":"2015082718040528000_173.4.M45.56","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0221"},{"key":"2015082718040528000_173.4.M45.57","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.8.2616"},{"key":"2015082718040528000_173.4.M45.58","doi-asserted-by":"crossref","unstructured":"Chabre O Liakos P Vivier J Bottari S Bachelot I Chambaz EM Feige JJ Defaye G . Gastric inhibitory polypeptide (GIP) stimulates cortisol secretion, cAMP production and DNA synthesis in an adrenal adenoma responsible for food-dependent Cushing's syndrome. Endocrine Research 1998 24 851\u2013856. (doi:10.3109\/07435809809032696).","DOI":"10.3109\/07435809809032696"},{"key":"2015082718040528000_173.4.M45.59","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0946"},{"key":"2015082718040528000_173.4.M45.60","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02411.x"},{"key":"2015082718040528000_173.4.M45.61","doi-asserted-by":"publisher","DOI":"10.1677\/jme.1.01765"},{"key":"2015082718040528000_173.4.M45.62","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.8.2781"},{"key":"2015082718040528000_173.4.M45.63","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0921"},{"key":"2015082718040528000_173.4.M45.64","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199911183412104"},{"key":"2015082718040528000_173.4.M45.65","doi-asserted-by":"crossref","unstructured":"Chui MH Ozbey NC Ezzat S Kapran Y Erbil Y Asa SL . Case report: adrenal LH\/hCG receptor overexpression and gene amplification causing pregnancy-induced Cushing's syndrome. Endocrine Pathology 2009 20 256\u2013261. (doi:10.1007\/s12022-009-9090-2).","DOI":"10.1007\/s12022-009-9090-2"},{"key":"2015082718040528000_173.4.M45.66","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020621"},{"key":"2015082718040528000_173.4.M45.67","doi-asserted-by":"publisher","DOI":"10.3109\/09513590009167660"},{"key":"2015082718040528000_173.4.M45.68","doi-asserted-by":"publisher","DOI":"10.1172\/JCI7716"},{"key":"2015082718040528000_173.4.M45.69","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2281"},{"key":"2015082718040528000_173.4.M45.70","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(86)90041-X"},{"key":"2015082718040528000_173.4.M45.71","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-08-0085"},{"key":"2015082718040528000_173.4.M45.72","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2476"},{"key":"2015082718040528000_173.4.M45.73","unstructured":"Matsukura S Kakita T Sueoka S Yoshimi H Hirata Y Yokota M Fujita T . Multiple hormone receptors in the adenylate cyclase of human adrenocortical tumors. Cancer Research 1980 40 3768\u20133771."},{"key":"2015082718040528000_173.4.M45.74","unstructured":"de Miguel V Redal MA Viale ML Kahan M Glerean M Beskow A Fainstein Day P . Aberrant expression of glucagon receptors in adrenal glands of a patient with Cushing's syndrome and ACTH-independent macronodular adrenal hyperplasia. Medicina 2010 70 254\u2013256."},{"key":"2015082718040528000_173.4.M45.75","doi-asserted-by":"crossref","unstructured":"Louiset E Duparc C Groussin L Gobet F Desailloud R Barrande G Reznik Y Bertherat J Prevost G Lefebvre H . Abnormal sensitivity to glucagon and related peptides in primary adrenal Cushing's syndrome. Hormone and Metabolic Research 2014 46 876\u2013882. (doi:10.1055\/s-0034-1384522).","DOI":"10.1055\/s-0034-1384522"},{"key":"2015082718040528000_173.4.M45.76","unstructured":"Xekouki P, Bram Z, Louiset E, Avgeropoulos D, Nesterova MV, Sinaii N, Lefebvre H & Stratakis CA. Expression of somatostatin receptors in normal adrenal and in primary pigmented nodular adrenocortical disease (PPNAD). A possible new use for somatostatin analogues. The Endocrine Society's 95th Annual Meeting and Expo, June 15\u201318, 2013 - San Francisco. Abstract, pp MON-8-MON-8"},{"key":"2015082718040528000_173.4.M45.77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03471.x"},{"key":"2015082718040528000_173.4.M45.78","doi-asserted-by":"publisher","DOI":"10.1385\/ENDO:19:3:319"},{"key":"2015082718040528000_173.4.M45.79","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02324"},{"key":"2015082718040528000_173.4.M45.80","doi-asserted-by":"publisher","DOI":"10.1210\/jc.76.1.189"},{"key":"2015082718040528000_173.4.M45.81","doi-asserted-by":"publisher","DOI":"10.1007\/s00063-002-1220-2"},{"key":"2015082718040528000_173.4.M45.82","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1996.682504.x"},{"key":"2015082718040528000_173.4.M45.83","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-34590"},{"key":"2015082718040528000_173.4.M45.84","doi-asserted-by":"publisher","DOI":"10.1677\/JOE-07-0413"},{"key":"2015082718040528000_173.4.M45.85","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021107"},{"key":"2015082718040528000_173.4.M45.86","doi-asserted-by":"crossref","unstructured":"Louiset E Cartier D Contesse V Duparc C Lihrmann I Young J Bertherat J Reznik Y Kuhn JM Laquerriere A . Paradoxical inhibitory effect of serotonin on cortisol production from adrenocortical lesions causing Cushing's syndrome. Endocrine Research 2004 30 951\u2013954. (doi:10.1081\/ERC-200044170).","DOI":"10.1081\/ERC-200044170"},{"key":"2015082718040528000_173.4.M45.87","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0538"},{"key":"2015082718040528000_173.4.M45.88","doi-asserted-by":"crossref","unstructured":"Fujii H Tamamori-Adachi M Uchida K Susa T Nakakura T Hagiwara H Iizuka M Okinaga H Tanaka Y Okazaki T . Marked cortisol production by intracrine ACTH in GIP-treated cultured adrenal cells in which the GIP receptor was exogenously introduced. PLoS ONE 2014 9 e110543. (doi:10.1371\/journal.pone.0110543).","DOI":"10.1371\/journal.pone.0110543"},{"key":"2015082718040528000_173.4.M45.89","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1312792"},{"key":"2015082718040528000_173.4.M45.90","doi-asserted-by":"crossref","unstructured":"Stratakis CA Sarlis N Kirschner LS Carney JA Doppman JL Nieman LK Chrousos GP Papanicolaou DA . Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Annals of Internal Medicine 1999 131 585\u2013591. (doi:10.7326\/0003-4819-131-8-199910190-00006).","DOI":"10.7326\/0003-4819-131-8-199910190-00006"},{"key":"2015082718040528000_173.4.M45.91","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0031"},{"key":"2015082718040528000_173.4.M45.92","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-022001"},{"key":"2015082718040528000_173.4.M45.93","doi-asserted-by":"publisher","DOI":"10.1210\/jc.77.2.494"},{"key":"2015082718040528000_173.4.M45.94","unstructured":"Bram Z, Wils J, Ragazzon B, Risk-Rabin M, Libe R, Young J, Vantyghem M-C, Martinez A, Stratakis CA, Bertherat JY, et al. \u03b2-estradiol (E2) stimulates cortisol secretion in primary pigmented nodular adrenal disease: an explanation for the increased frequency of Cushing's syndrome in female patients with Carney complex. The Endocrine Society's 96th Meeting and 16th International Congress of Endocrinology (ICE-ENDO 2014), Chicago, June 21\u201324 2014 \u2013 Abstract OR14-12"},{"key":"2015082718040528000_173.4.M45.95","doi-asserted-by":"publisher","DOI":"10.1126\/science.1198785"},{"key":"2015082718040528000_173.4.M45.96","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2695"},{"key":"2015082718040528000_173.4.M45.97","unstructured":"Beuschlein F Boulkroun S Osswald A Wieland T Nielsen HN Lichtenauer UD Penton D Schack VR Amar L Fischer E . Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nature Genetics 2013 45 pp 440\u2013444, 444e441\u2013442 doi:10.1038\/ng.2550)."},{"key":"2015082718040528000_173.4.M45.98","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-14-0597"},{"key":"2015082718040528000_173.4.M45.99","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0711"},{"key":"2015082718040528000_173.4.M45.100","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2001.01253.x"},{"key":"2015082718040528000_173.4.M45.101","doi-asserted-by":"publisher","DOI":"10.1677\/JOE-07-0037"},{"key":"2015082718040528000_173.4.M45.102","doi-asserted-by":"crossref","unstructured":"Arnaldi G Mancini V Costantini C Giovagnetti M Petrelli M Masini A Bertagna X Mantero F . ACTH receptor mRNA in human adrenocortical tumors: overexpression in aldosteronomas. Endocrine Research 1998 24 845\u2013849. (doi:10.3109\/07435809809032695).","DOI":"10.3109\/07435809809032695"},{"key":"2015082718040528000_173.4.M45.103","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.3.1211"},{"key":"2015082718040528000_173.4.M45.104","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1298"},{"key":"2015082718040528000_173.4.M45.105","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020067"},{"key":"2015082718040528000_173.4.M45.106","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1453"},{"key":"2015082718040528000_173.4.M45.107","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(02)00658-2"},{"key":"2015082718040528000_173.4.M45.108","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02051"},{"key":"2015082718040528000_173.4.M45.109","doi-asserted-by":"crossref","unstructured":"Gross MD Grekin RJ Gniadek TC Villareal JZ . Suppression of aldosterone by cyproheptadine in idiopathic aldosteronism. New England Journal of Medicine 1981 305 181\u2013185. (doi:10.1056\/NEJM198107233050401).","DOI":"10.1056\/NEJM198107233050401"},{"key":"2015082718040528000_173.4.M45.110","doi-asserted-by":"crossref","unstructured":"Mantero F Rocco S Opocher G Armanini D Boscaro M D'Agostino D . Effect of ketanserin in primary aldosteronism. Journal of Cardiovascular Pharmacology 1985 7 (Suppl 7) S172\u2013S175. (doi:10.1097\/00005344-198500077-00048).","DOI":"10.1097\/00005344-198500077-00048"},{"key":"2015082718040528000_173.4.M45.111","doi-asserted-by":"publisher","DOI":"10.1210\/er.19.2.101"},{"key":"2015082718040528000_173.4.M45.112","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.10.5001"},{"key":"2015082718040528000_173.4.M45.113","unstructured":"Maltby S Khazaie K McNagny KM . Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation. Biochimica et Biophysica Acta 2009 1796 19\u201326. (doi:10.1016\/j.bbcan.2009.02.001)."},{"key":"2015082718040528000_173.4.M45.114","doi-asserted-by":"publisher","DOI":"10.1038\/nm1649"},{"key":"2015082718040528000_173.4.M45.115","doi-asserted-by":"crossref","unstructured":"Duparc C Moreau L Felipe Golib Dzib J Boyer HG Tetsi Nomigni M Boutelet I Boulkroun S Mukai K Benecke AG Amar L . Mast cell hyperplasia is associated with aldosterone hypersecretion in a subset of aldosterone-producing adenomas. Journal of Clinical Endocrinology and Metabolism 2015 100 E550\u2013E560. (doi:10.1210\/jc.2014-3660).","DOI":"10.1210\/jc.2014-3660"},{"key":"2015082718040528000_173.4.M45.116","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1340"},{"key":"2015082718040528000_173.4.M45.117","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199711133372004"},{"key":"2015082718040528000_173.4.M45.118","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0879"},{"key":"2015082718040528000_173.4.M45.119","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.2.583"},{"key":"2015082718040528000_173.4.M45.120","doi-asserted-by":"crossref","unstructured":"Leinonen P Ranta T Siegberg R Pelkonen R Heikkila P Kahri A . Testosterone-secreting virilizing adrenal adenoma with human chorionic gonadotrophin receptors and 21-hydroxylase deficiency. Clinical Endocrinology 1991 34 31\u201335. (doi:10.1111\/j.1365-2265.1991.tb01732.x).","DOI":"10.1111\/j.1365-2265.1991.tb01732.x"},{"key":"2015082718040528000_173.4.M45.121","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021292"},{"key":"2015082718040528000_173.4.M45.122","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.5.1768"},{"key":"2015082718040528000_173.4.M45.123","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04179.x"},{"key":"2015082718040528000_173.4.M45.124","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1992"},{"key":"2015082718040528000_173.4.M45.125","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.8.2439"},{"key":"2015082718040528000_173.4.M45.126","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0235"},{"key":"2015082718040528000_173.4.M45.127","doi-asserted-by":"publisher","DOI":"10.1172\/JCI60417"},{"key":"2015082718040528000_173.4.M45.128","doi-asserted-by":"crossref","unstructured":"Reincke M Sbiera S Hayakawa A Theodoropoulou M Osswald A Beuschlein F Meitinger T Mizuno-Yamasaki E Kawaguchi K Saeki Y . Mutations in the deubiquitinase gene USP8 cause Cushing's disease. Nature Genetics 2015 47 31\u201338. (doi:10.1038\/ng.3166).","DOI":"10.1038\/ng.3166"},{"key":"2015082718040528000_173.4.M45.129","doi-asserted-by":"crossref","unstructured":"Ma ZY Song ZJ Chen JH Wang YF Li SQ Zhou LF Mao Y Li YM Hu RG Zhang ZY . Recurrent gain-of-function USP8 mutations in Cushing's disease. Cell Research 2015 25 306\u2013317. (doi:10.1038\/cr.2015.20).","DOI":"10.1038\/cr.2015.20"},{"key":"2015082718040528000_173.4.M45.130","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-34-3-447"},{"key":"2015082718040528000_173.4.M45.131","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-08-0190"},{"key":"2015082718040528000_173.4.M45.132","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0907843106"},{"key":"2015082718040528000_173.4.M45.133","doi-asserted-by":"crossref","unstructured":"Umahara M Okada S Ohshima K Mori M . Glucose-dependent insulinotropic polypeptide induced growth hormone secretion in acromegaly. Endocrine Journal 2003 50 643\u2013650. (doi:10.1507\/endocrj.50.643).","DOI":"10.1507\/endocrj.50.643"},{"key":"2015082718040528000_173.4.M45.134","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2826.2011.02155.x"},{"key":"2015082718040528000_173.4.M45.135","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-44-2-392"},{"key":"2015082718040528000_173.4.M45.136","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-31-3-239"},{"key":"2015082718040528000_173.4.M45.137","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-51-2-292"},{"key":"2015082718040528000_173.4.M45.138","doi-asserted-by":"publisher","DOI":"10.1210\/en.138.2.827"},{"key":"2015082718040528000_173.4.M45.139","doi-asserted-by":"crossref","unstructured":"Arihara Z Sakurai K Osaki Y Fukazawa H Yamada S Inoshita N Murakami O Ohba K Takahashi K . ACTH response to desmopressin in a patient with acromegaly; expression of corticotropin-releasing factor, urocortins and vasopressin V1b receptor in GH-producing pituitary adenoma. Endocrine Journal 2011 58 1029\u20131036. (doi:10.1507\/endocrj.EJ11-0038).","DOI":"10.1507\/endocrj.EJ11-0038"},{"key":"2015082718040528000_173.4.M45.140","doi-asserted-by":"crossref","unstructured":"Albiger NM Ceccato F Zilio M Barbot M Occhi G Rizzati S Fassina A Mantero F Boscaro M Iacobone M . An analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: a single-centre experience. Clinical Endocrinology 2015 82 808\u2013815. (doi:10.1111\/cen.12763).","DOI":"10.1111\/cen.12763"},{"key":"2015082718040528000_173.4.M45.141","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-27302007000900007"},{"key":"2015082718040528000_173.4.M45.142","doi-asserted-by":"crossref","unstructured":"Preumont V Mermejo LM Damoiseaux P Lacroix A Maiter D . Transient efficacy of octreotide and pasireotide (SOM230) treatment in GIP-dependent Cushing's syndrome. Hormone and Metabolic Research 2011 43 287\u2013291. (doi:10.1055\/s-0030-1270523).","DOI":"10.1055\/s-0030-1270523"},{"key":"2015082718040528000_173.4.M45.143","doi-asserted-by":"crossref","unstructured":"Karapanou O Vlassopoulou B Tzanela M Stratigou T Tsatlidis V Tsirona S Tsagarakis S . Adrenocorticotropic hormone independent macronodular adrenal hyperplasia due to aberrant receptor expression: is medical treatment always an option? Endocrine Practice 2013 19 e77\u2013e82. (doi:10.4158\/EP12346.CR).","DOI":"10.4158\/EP12346.CR"},{"key":"2015082718040528000_173.4.M45.144","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00490.x"},{"key":"2015082718040528000_173.4.M45.145","doi-asserted-by":"crossref","unstructured":"Nakamura Y Son Y Kohno Y Shimono D Kuwamura N Koshiyama H Sasano H Matsuda T . Case of adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with possible adrenal hypersensitivity to angiotensin II. Endocrine 2001 15 57\u201361. (doi:10.1385\/ENDO:15:1:057).","DOI":"10.1385\/ENDO:15:1:057"},{"key":"2015082718040528000_173.4.M45.146","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K08E-370"},{"key":"2015082718040528000_173.4.M45.147","doi-asserted-by":"crossref","unstructured":"Fragoso MC Alencar GA Lerario AM Bourdeau I Almeida MQ Mendonca BB Lacroix A . Genetics of primary macronodular adrenal hyperplasia. Journal of Endocrinology 2015 224 R31\u2013R43. (doi:10.1530\/JOE-14-0568).","DOI":"10.1530\/JOE-14-0568"},{"key":"2015082718040528000_173.4.M45.148","doi-asserted-by":"crossref","unstructured":"Pl\u00f6ckinger U, Tiling N, Blankenstein O, von Weizs\u00e4cker K, Allolio B, Kroiss M, Hauptmann K, Saeger W, Radke C, Steinm\u00fcller T et al. Transient pregnancy-induced Cushing's syndrome with aberrant adrenal hCG receptor. Experimental and Clinical Endocrinology & Diabetes 2014 122 P137. (doi:10.1055\/s-0034-1372154).","DOI":"10.1055\/s-0034-1372154"},{"key":"2015082718040528000_173.4.M45.149","doi-asserted-by":"crossref","unstructured":"Lefebvre H Pr\u00e9vost G Louiset E . Could targeting hormone receptors be an effective strategy in management of adrenal hyperplasia? International Journal of Endocrine Oncology 2014 1 11\u201314. (doi:10.2217\/ije.14.10).","DOI":"10.2217\/ije.14.10"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/173\/4\/M45.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/173\/4\/M45.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T16:32:35Z","timestamp":1676392355000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/173\/4\/M45\/6660790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":149,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1530\/eje-15-0200","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}